Abstract
In this study, the effect of dexamethasone on the formation of pneumococcal antibodies during community-acquired pneumonia (CAP) was investigated. No differences between CAP patients receiving dexamethasone as additional therapy and patients receiving a placebo were found with respect to immune response rates and mean baseline and convalescent-phase antibody concentrations.
| Original language | English |
|---|---|
| Pages (from-to) | 811-813 |
| Number of pages | 3 |
| Journal | Clinical and Vaccine Immunology |
| Volume | 19 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - 2012 |
Keywords
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Bacterial
- Antineoplastic Agents
- Community-Acquired Infections
- Dexamethasone
- Double-Blind Method
- Female
- Humans
- Male
- Middle Aged
- Placebos
- Pneumonia, Pneumococcal
- Journal Article
- Randomized Controlled Trial
Fingerprint
Dive into the research topics of 'Dexamethasone treatment has no effect on the formation of pneumococcal antibodies during community-acquired pneumonia'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver